Black tea prevents high fat diet-induced non-alcoholic steatohepatitis

Phytotherapy Research

Volumn 25, Issue 7, 2011, Pages 1073-1081

  Karmakar, Subhra ^a,b   Das, Dolan ^a,c   Maiti, Anasuya ^a,c   Majumdar, Sangita ^a,d   Mukherjee, Piyal ^a   Das, Asankur S ^a,b   Mitra, Chandan ^a,b  

^a PRESIDENCY UNIVERSITY   (India)

^b Pre Clinical Physiology Laboratory   (India)

^c Kalyani Mahavidhyalaya ^*  (India)

^d Haldia Institute of Dental Sciences and Research   (India)

Author keywords

Apoptotic changes; Black tea; Chemoprotection; Hepatocellular damage; Non alcoholic steatohepatitis; Pro oxidative and antioxidative markers

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BLACK TEA EXTRACT; CASPASE 3; CATALASE; CHOLESTEROL; GLUCOSE; GLUTATHIONE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CHEMOPROPHYLAXIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DNA FRAGMENTATION; ENZYME ACTIVITY; ENZYME REPRESSION; ENZYME SYNTHESIS; FEMALE; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; LIPID DIET; LIPID PEROXIDATION; LIPOPROTEIN BLOOD LEVEL; LIVER FUNCTION; LIVER PROTECTION; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PROTEIN DEPLETION; PROTEIN EXPRESSION; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

CAMELLIA SINENSIS; RATTUS; RATTUS NORVEGICUS;

EID: 84860402707     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3466     Document Type: Article

References (70)

1. Andy S, Yu MD, Emmet B, Keeffe MD. 2002. Nonalcoholic fatty liver disease. Rev Gastroenterol Disord 2:11-19.
2. Archivio MD, Santangelo C, Scazzocchio B et al. 2008. Modulatory effects of polyphenols on apoptosis induction: Relevance for cancer prevention. Int J Mol Sci 9:213-228. (Pubitemid 351482110)
3. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. 1994. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 107:1103-1109. (Pubitemid 24294573)
4. Bahrami H, Daryani NS, Miromen S, Kamangar F, Haghpanah B, Djalili M. 2003. Clinical and histological features of nonalcoholic steatohepatitis in Iranian patients. BMC Gastroenterol 3:27.
5. Bancroft JD, Stevens A, Turner DR. 1996. Theory and Practice of Histological Techniques. Churchill Livingstone: New York, 104.
6. Banerjee S, Maity P, Mukherjee S et al. 2007. Black tea prevents cigarette smoke-induced apoptosis and lung damage. J Immunol 4:3.
7. Basaranoglu M, Neuschwander-Tetri BA. 2006. Nonalcoholic fatty liver disease: Clinical features and pathogenesis. Gastroenterol Hepatol 2:282-291. (Pubitemid 46085670)
8. Baumgardner J, Shankar K, Badger TM, Ronis MJ. 2005. A new rat model for non-alcoholic steatohepatitis. In Proceedings of the South Central Chapter of the Society of Toxicology, 24th Annual Meeting, Little Rock, Arkansas, 18.
9. Bhattacharya A, Mandal D, Lahiry L et al. 2007. Black tea-induced amelioration of hepatic oxidative stress through antioxidative activity in EAC-bearing mice. J Environ Pathol Toxical Oncol 26:245-254.
10. Bray PC, Cockle SA, Fielden EM, Roberts PB, Rotilio G, Calabrese L. 1974. Reduction and inactivation of superoxide dismutase by hydrogen peroxide. Biochem J 139:43-48.
11. Brunt EM, Janney C, Bisceglie AD, Neuschwander-Tetri B, Bacon B. 1999. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94:2467-2474. (Pubitemid 29420675)
12. Chalasani N, Deeg MA, Crabb DW. 2004. Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 99:1497-1502. (Pubitemid 39193189)
13. Cohen G, Dembiec D, Marcus J. 1970. Measurement of catalase activity in tissue extract. Anal Biochem 34:30-37.
14. Davies MJ, Judd JT, Baer DJ et al. 2003. Black tea consumption reduces total and LDL cholesterol in mildly hypercholesterolemic adults. J Nutr 133:3298S-3302S. (Pubitemid 37222259)
15. Day CP, James O. 1998. Steatohepatitis: a tale of two 'hits'? Gastroenterology 114:842-845. (Pubitemid 28160420)
16. Dufrense CJ, Farnworth ER. 2001. A review of latest research findings on the health promotion properties of tea. J Nutr Biochem 12:404-421. (Pubitemid 32633828)
17. Dunlap FG, White PJ, Pollak LM. 1995. Fatty acid composition of oil from exotic corn breeding materials. J Am Oil Chem Soc 72:989-993.
18. Edem DO, Akpanabiatu MI. 2006. Effects of palm-oil containing diets on enzyme activities of rats. Pak J Nutr 5:301-305.
19. Ellman GL. 1959. Tissue sulfhydryl groups. Arch Biochem 82:70-77.
20. Escober JA, Rubio M, Lissi EA. 1996. SOD and catalase inactivation by singlet oxygen and peroxyl radicals. Free Radic Biol Med 20:285-290. (Pubitemid 26077850)
21. Fang FC. 1997. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest 99:2818-2825. (Pubitemid 27278655)
22. Farrell GC. 2003. Non-alcoholic steatohepatitis: what is it and why is it important in the Asia-Pacific region? J Gastroenterol Hepatol 18:124-138. (Pubitemid 36349857)
23. Frei B, Higdon JV. 2003. Antioxidant activity of tea polyphenols in vivo: Evidence from animal studies. J Nutr 133:3275S-3284S. (Pubitemid 37222256)
24. Hierholzer C, Harbrecht B, Menezes JM et al. 1998. Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock. J Exp Med 187:917-928. (Pubitemid 28141665)
25. Hodgson EK, Fridovich I. 1975. The interaction of bovine erythrocyte superoxide dismutase with hydrogen peroxide: inactivation of the enzyme. Biochemistry 14:5294-5299.
26. Imai K, Nakachi K. 1995. Cross sectional study of effectsof drinking green tea on cardiovascular and liver disease. Br Med J 310:693-696.
27. Kalf JC, Schraut WH, Billiar JR, Simmons RL, Bauer AJ. 2000. Role of inducible nitric oxide synthase in postoperative intestinal smooth muscle dysfunction in rodents. Gastroenterology 118:316-327. (Pubitemid 30067505)
28. Kaplowitz N. 1992. Liver and Biliary Diseases. Williams and Wilkins: Baltimore.
29. Katiyar SK, Mukhtar H. 1996. Tea in chemoprevention of cancer: Epidemiologic and experimental studies. Int J Oncol 8:221-238.
30. Khan SM. 2006. Protective effect of BTE on the levels of lipid peroxidation and antioxidant enzymes in liver of mice with pesticide-induced liver injury. Cell Biochem Funct 24:327-332. (Pubitemid 44065235)
31. Kono Y, Fridovich I. 1975. Superoxide radical inhibits catalase. J Biol Chem 257:5751-5754.
32. Koyama I, Tsugikazu K, Yoshikatsu S, Munetsugu K. 1983. A possible mechanism for the changes in hepatic and intestinal alkaline phosphatase activities in bile duct ligated rats and guinea pigs. Biochem Biophys Acta 760:169-174. (Pubitemid 13013475)
33. Krippeit-Drews P, Kroncke KD, Welker S et al. 1995. The effects of nitric oxide on the membrane potential and ionic currents of mouse pancreatic B cells. Endocrinology 136:5363-5369.
34. Krishnamoorthy KK. 1991. The nutritional and therapeutic value of tea. In Proceedings of International Symposium on Tea Science, Yamanishi T (ed). Organizing Committee of ISTS: Shizuoka, Japan; 6-11.
35. Langley-Evans SC. 2000. Antioxidant potential of green and black tea determined using the ferric reducing power (FRAP) assay. Int J Food Sci Nutr 51:181-188. (Pubitemid 30411823)
36. Leclercq IA, Farrel GC, Field J, Bell DR, Gonzalez FJ, Robertson GR. 2000. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J Clin Invest 105:1067-1075. (Pubitemid 30217691)
37. Lee RG. 1989. Nonalcoholic steatohepatitis: a study of 49 patients. Hum Pathol 20:594-598. (Pubitemid 19164370)
38. Lieber CS. 1997. Cytochrome P-4502E1: its physiological and pathological role. Physiol Rev 77:517-544. (Pubitemid 27184347)
39. Ludwig J, Viggiano TR, McGill DB, Oh BJ. 1980. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55:434-438. (Pubitemid 10057164)
40. Lynn S, Shiung JN, Gurr JR, Jan KY. 1998. Arsenite stimulates poly (ADP-ribosylation) by generation of nitric oxide. Free Radic Biol Med 24:442-449. (Pubitemid 28008789)
41. Matsumoto N, Tono-Oka F, Ishigaki A, Okushio K, Hara Y. 1991. The fate of (-)-epigallocatechin gallate (EGCg) in the digestive tract of rats. In Proceedings of International Symposium on Tea Science, Yamanishi T (ed). Organizing Committee of ISTS: Shizuoka, Japan; 253-257.
42. Matsuzaki T, Hara Y. 1985. Antioxidative activity of tea leaf catechins. J Agric Chem Soc 59:129-134.
43. Misra HP, Fridovich I. 1972. The role of superoxide anion in the antioxidation of epinephrine: a simple assay for superoxide dismutase. J Biol Chem 247:3170-3175.
44. Monzon-Garcia C, Majano PL, Zubia I, Sanz P, Apolinaria A, Moreno-Otero R. 2000. Intrahepatic accumulation of nitrotyrosine in chronic viral hepatitis is associated with histological severity of liver disease. J Hepatol 32:331-338. (Pubitemid 30093914)
45. Mukherjee A, Chowdhury S, Roy A, Mukherjee A, Datta UK. 1991. Antidiabetic effect of black tea (Camellia sinensis) in human. Indian J Physiol Allied Sci 53:96-98.
46. Nag Chaudhuri AK, Karmakar S, Roy D, Pal S, Pal M, Sen T. 2005. Anti-inflammatory activity of Indian black tea (Sikkim variety). Pharmacol Res 51:169-175. (Pubitemid 40040549)
47. Nussler AK, Billiar TR. 1993. Inflammation, immunoregulation, and inducible nitric oxide synthase. J Leukoc Biol 54:171-178. (Pubitemid 23276408)
48. Oldenburg B, Pijli H. 2001. Abdominal obesity: metabolic complications and consequences for the liver. Ned Tijdschr Geneeskd 145:1290-1294. (Pubitemid 32619533)
49. Paquay JB, Haenen GR, Stender G, Wiseman SA, Tijberg LB, Bast A. 2000. Protection against nitric oxide toxicity by tea. J Agric Food Chem 48:5768-5772.
50. Pessayre D, Berson A, Fromenty B, Mansouri A. 2001. Mitochondria of living cell injury. J Hepatol 32:39-47.
51. Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW. 1990. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 11:74-80. (Pubitemid 20075105)
52. Raso GM, Meli R, Gualillo O, Pacilio M, Di Carlo R. 1999. Prolactin induction of nitric oxide synthase in rat C6 glioma cells. J Neurochem 73:2272-2277.
53. Samuhasaneeto S, Thong Ngam D, Kulaputana O, Patumraj S, Klaikeaw N. 2007. Effects of N-acetylcysteine on oxidative stress in rats with non-alcoholic steatohepatitis. J Med Assoc Thai 90:788-797.
54. Sano M, Takahashi Y, Komatsu C et al. 1991. Anti-oxidative activities of green tea and black tea in rat organ and blood plasma. Proceedings of the International Symposium on Tea Science, Japan, 304-313.
55. Sarkar A, Bhaduri A. 2001. Black tea is a powerful chemopreventor of reactive oxygen and nitrogen species: comparison with its individual catechin constituents and green tea. Biochem Biophys Res Commun 284:173-178. (Pubitemid 32924324)
56. Scheen AJ, Luyckx FH. 2002. Obesity and liver disease. Best Pract Res Clin Endocrinol Metab 16:703-716.
57. Shuichi S, Takuya K, Sakaguchi H. 2005. Clinicopathological significance of oxidative cellular damage in non-alcoholic fatty liver diseases. Hepatol Res 30:132-134. (Pubitemid 41799790)
58. Tichauer JE, Morales MG, Amigo L et al. 2007. Overexpression of the cholesterol-binding protein MLN64 induces liver damage in the mouse. World J Gastroenterol 13:3071-3079. (Pubitemid 47045464)
59. Tiniakos DG, Kittas CH. 2005. Pathology of nonalcoholic fatty liver disease. Annals Gastroenterol 18:148-159.
60. Uno M, Kurita S, Misu H et al. 2008. Tranilast, an antifibrogenic agent, ameliorates a delivery rat model of non-alcoholic steatohepatitis. Hepatology 48:109-118. (Pubitemid 351975536)
61. Varela NM, Quiones LA, Orellana M et al. 2008. Study of cytochrome P4502E1 and its allele variants in liver injury of nondiabetic, nonalcoholic steatohepatitis obese women. Biol Res 41:81-92.
62. Vinson J, Zhang J. 2005. In rats, black and green tea lower blood sugar prevents cataracts. J Agric Food Chem; Source: http:/www.webmed.com/content/ article/104/107553.htm.
63. Vinson JA, Dabbagh YA. 1998. Effect of green and black tea supplementation on lipids, lipid oxidation and fibrogen in the hamster: mechanism for the epidemiological benefits of tea drinking. FEBS Lett 433:44-46. (Pubitemid 28386729)
64. Wanless IR, Lentz JS. 1990. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 12:1106-1110.
65. Wei H, Zhang X, Zhao JF, Wang ZY, Bickers D, Lebwohl M. 1999. Scavenging of hydrogen peroxide and inhibition of ultraviolet light-induced oxidative DNA damage by aqueous extracts from green and black teas. Free Radic Biol Med 26:1427-1435. (Pubitemid 29302274)
66. Wieckowska A, McCullough AJ, Feldstein AE. 2007. Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: Present and future. Hepatology 46:582-589. (Pubitemid 47344794)
67. Wills ED. 1987. Evaluation of lipid peroxidation in lipids and biological membranes. In Biochemical Toxicology - A Practical Approach, Snell K, Mullock B (eds). IRL Press: Oxford, 138.
68. Yabuki M, Kariya S, Ishisaka R et al. 1999. Resistance to nitric oxide-mediated apoptosis in HL-60 variant cells is associated with increased activities of Cu, Zn-superoxide dismutase and catalase. Free Radic Biol Med 26:325-332. (Pubitemid 29013463)
69. Youssef W, McCullough AJ. 2002. Diabetes mellitus, obesity, and hepatic steatosis. Semin Gastrointest Dis 13:17-30. (Pubitemid 34262948)
70. Zhou Z, Sun X, Jams Kang Y. 2001. Ethanol-induced apoptosis in mouse liver: Fas-and cytochrome c-mediated caspase-3 activation pathway. Am J Pathol 159:329-338. (Pubitemid 33704218)